163 related articles for article (PubMed ID: 11600235)
1. Synthesis and steroid sulphatase inhibitory activity of C19- and C21-steroidal derivatives bearing a benzyl-inhibiting group.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
Eur J Med Chem; 2001; 36(7-8):659-71. PubMed ID: 11600235
[TBL] [Abstract][Full Text] [Related]
2. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of 17alpha-derivatives of estradiol as inhibitors of steroid sulfatase.
Boivin RP; Luu-The V; Lachance R; Labrie F; Poirier D
J Med Chem; 2000 Nov; 43(23):4465-78. PubMed ID: 11087571
[TBL] [Abstract][Full Text] [Related]
4. Assessment of steroidogenesis and steroidogenic enzyme functions.
Luu-The V
J Steroid Biochem Mol Biol; 2013 Sep; 137():176-82. PubMed ID: 23770321
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in the development of steroid sulphatase inhibitors.
Purohit A; Hejaz HA; Woo LW; van Strien AE; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1999; 69(1-6):227-38. PubMed ID: 10418996
[TBL] [Abstract][Full Text] [Related]
6. Potent active site-directed inhibition of steroid sulphatase by tricyclic coumarin-based sulphamates.
Woo LL; Purohit A; Malini B; Reed MJ; Potter BV
Chem Biol; 2000 Oct; 7(10):773-91. PubMed ID: 11033081
[TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
[TBL] [Abstract][Full Text] [Related]
8. 17Alpha-alkan (or alkyn) amide derivatives of estradiol as inhibitors of steroid-sulfatase activity.
Boivin RP; Labrie F; Poirier D
Steroids; 1999 Dec; 64(12):825-33. PubMed ID: 10576217
[TBL] [Abstract][Full Text] [Related]
9. The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity.
Purohit A; Vernon KA; Hummelinck AE; Woo LW; Hejaz HA; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1998 Mar; 64(5-6):269-75. PubMed ID: 9618028
[TBL] [Abstract][Full Text] [Related]
10. The hydrolysis of oestrone sulphate and dehydroepiandrosterone sulphate by human steroid sulphatase expressed in transfected COS-1 cells.
Purohit A; Dauvois S; Parker MG; Potter BV; Williams GJ; Reed MJ
J Steroid Biochem Mol Biol; 1994 Jul; 50(1-2):101-4. PubMed ID: 8049127
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of steryl sulfatase activity in LNCaP human prostate cancer cells.
Selcer KW; Kabler H; Sarap J; Xiao Z; Li PK
Steroids; 2002 Sep; 67(10):821-6. PubMed ID: 12231117
[TBL] [Abstract][Full Text] [Related]
12. Potent and selective steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 7, an enzyme that catalyzes the reduction of the key hormones estrone and dihydrotestosterone.
Bellavance E; Luu-The V; Poirier D
J Med Chem; 2009 Dec; 52(23):7488-502. PubMed ID: 19772289
[TBL] [Abstract][Full Text] [Related]
13. In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate.
Purohit A; Williams GJ; Roberts CJ; Potter BV; Reed MJ
Int J Cancer; 1995 Sep; 63(1):106-11. PubMed ID: 7558436
[TBL] [Abstract][Full Text] [Related]
14. Interaction of Androst-5-ene-3β,17β-diol and 5α-androstane-3β,17β-diol with estrogen and androgen receptors: a combined binding and cell study.
Chen J; Wang WQ; Lin SX
J Steroid Biochem Mol Biol; 2013 Sep; 137():316-21. PubMed ID: 23416106
[TBL] [Abstract][Full Text] [Related]
15. Characterization of 17alpha-hydroxysteroid dehydrogenase activity (17alpha-HSD) and its involvement in the biosynthesis of epitestosterone.
Bellemare V; Faucher F; Breton R; Luu-The V
BMC Biochem; 2005 Jul; 6():12. PubMed ID: 16018803
[TBL] [Abstract][Full Text] [Related]
16. Human granulosa cells are a site of sulphatase activity and are able to utilize dehydroepiandrosterone sulphate as a precursor for oestradiol production.
Bonser J; Walker J; Purohit A; Reed MJ; Potter BV; Willis DS; Franks S; Mason HD
J Endocrinol; 2000 Dec; 167(3):465-71. PubMed ID: 11115773
[TBL] [Abstract][Full Text] [Related]
17. Nonsteroidal compounds designed to mimic potent steroid sulfatase inhibitors.
Ciobanu LC; Luu-The V; Poirier D
J Steroid Biochem Mol Biol; 2002 Mar; 80(3):339-53. PubMed ID: 11948019
[TBL] [Abstract][Full Text] [Related]
18. Immune enhancing effects of dehydroepiandrosterone and dehydroepiandrosterone sulphate and the role of steroid sulphatase.
Suitters AJ; Shaw S; Wales MR; Porter JP; Leonard J; Woodger R; Brand H; Bodmer M; Foulkes R
Immunology; 1997 Jun; 91(2):314-21. PubMed ID: 9227333
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of steroid sulphatase activity by steroidal methylthiophosphonates: potential therapeutic agents in breast cancer.
Purohit A; Howarth NM; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 1994 Apr; 48(5-6):523-7. PubMed ID: 8180114
[TBL] [Abstract][Full Text] [Related]
20. Steroid sulphatase: expression, isolation and inhibition for active-site identification studies.
Purohit A; Potter BV; Parker MG; Reed MJ
Chem Biol Interact; 1998 Feb; 109(1-3):183-93. PubMed ID: 9566745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
